Ascendis Pharma
ASND
#1252
Rank
โ‚น1.699 T
Marketcap
โ‚น25,903
Share price
3.12%
Change (1 day)
34.94%
Change (1 year)

Earnings for Ascendis Pharma (ASND)

Earnings in 2026 (TTM): โ‚น23.95 Billion

According to Ascendis Pharma 's latest financial reports the company's current earnings are โ‚น1.21 Billion. In 2025 the company made an earning of -โ‚น11.52 Billion, an increase over its 2024 earnings that were of -โ‚น27.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ascendis Pharma from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น23.95 B-307.92%
2025 -โ‚น11.52 Billion-57.34%
2024 -โ‚น27.01 Billion-37.13%
2023 -โ‚น42.96 Billion-13.46%
2022 -โ‚น49.64 Billion23.12%
2021 -โ‚น40.32 Billion-10.49%
2020 -โ‚น45.04 Billion104.55%
2019 -โ‚น22.02 Billion61.09%
2018 -โ‚น13.67 Billion1.03%
2017 -โ‚น13.53 Billion89.6%
2016 -โ‚น7.14 Billion104.12%
2015 -โ‚น3.5 Billion185.04%
2014 -โ‚น1.23 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Akebia Therapeutics
AKBA
-โ‚น4.07 Billion-117.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-โ‚น7.2 Billion-130.66%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Advaxis
ADXS.defunct
-โ‚น3.21 Billion-113.64%๐Ÿ‡บ๐Ÿ‡ธ USA